Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1017/erm.2016.13 http://scihub22266oqcxt.onion/10.1017/erm.2016.13 C5001507!5001507 !27341512     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27341512 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Expert+Rev+Mol+Med 2016 ; 18 (ä): e12 Nephropedia Template TP {{tp|p=27341512 |t=2016. The immunological landscape in necrotising enterocolitis |pdf=|usr=}}{{27341512 }} gab.com Text The immunological landscape in necrotising enterocolitis JO: Expert Rev Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=27341512 #FOAvip Necrotising enterocolitis (NEC) is an uncommon, but devastating intestinal inflammatory disease that predominantly affects preterm infants. NEC is sometimes dubbed the spectre of neonatal intensive care units, as its onset is insidiously non-specific, and once the disease manifests, the damage inflicted on the baby's intestine is already disastrous. Subsequent sepsis and multi-organ failure entail a mortality of up to 65%. Development of effective treatments for NEC has stagnated, largely because of our lack of understanding of NEC pathogenesis. It is clear, however, that NEC is driven by a profoundly dysregulated immune system. NEC is associated with local increases in pro-inflammatory mediators, e.g. Toll-like receptor (TLR) 4, nuclear factor-?B, tumour necrosis factor, platelet-activating factor (PAF), interleukin (IL)-18, interferon-gamma, IL-6, IL-8 and IL-1?. Deficiencies in counter-regulatory mechanisms, including IL-1 receptor antagonist (IL-1Ra), TLR9, PAF-acetylhydrolase, transforming growth factor beta (TGF-?)1&2, IL-10 and regulatory T cells likely facilitate a pro-inflammatory milieu in the NEC-afflicted intestine. There is insufficient evidence to conclude a predominance of an adaptive Th1-, Th2- or Th17-response in the disease. Our understanding of the accompanying regulation of systemic immunity remains poor; however, IL-1Ra, IL-6, IL-8 and TGF-?1 show promise as biomarkers. Here, we chart the emerging immunological landscape that underpins NEC by reviewing the involvement and potential clinical implications of innate and adaptive immune mediators and their regulation in NEC. Twit Text FOAVip The immunological landscape in necrotising enterocolitis ????Expert Rev Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=27341512 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27341512 #FOAvip English Wikipedia <ref>{{Cite pmid|27341512 }}</ref> The immunological landscape in necrotising enterocolitis #MMPMID27341512 Cho SX ; Berger PJ ; Nold-Petry CA ; Nold MF Expert Rev Mol Med 2016[Jun]; 18 (ä): e12 PMID27341512 show ga Necrotising enterocolitis (NEC) is an uncommon, but devastating intestinal inflammatory disease that predominantly affects preterm infants. NEC is sometimes dubbed the spectre of neonatal intensive care units, as its onset is insidiously non-specific, and once the disease manifests, the damage inflicted on the baby's intestine is already disastrous. Subsequent sepsis and multi-organ failure entail a mortality of up to 65%. Development of effective treatments for NEC has stagnated, largely because of our lack of understanding of NEC pathogenesis. It is clear, however, that NEC is driven by a profoundly dysregulated immune system. NEC is associated with local increases in pro-inflammatory mediators, e.g. Toll-like receptor (TLR) 4, nuclear factor-?B, tumour necrosis factor, platelet-activating factor (PAF), interleukin (IL)-18, interferon-gamma, IL-6, IL-8 and IL-1?. Deficiencies in counter-regulatory mechanisms, including IL-1 receptor antagonist (IL-1Ra), TLR9, PAF-acetylhydrolase, transforming growth factor beta (TGF-?)1&2, IL-10 and regulatory T cells likely facilitate a pro-inflammatory milieu in the NEC-afflicted intestine. There is insufficient evidence to conclude a predominance of an adaptive Th1-, Th2- or Th17-response in the disease. Our understanding of the accompanying regulation of systemic immunity remains poor; however, IL-1Ra, IL-6, IL-8 and TGF-?1 show promise as biomarkers. Here, we chart the emerging immunological landscape that underpins NEC by reviewing the involvement and potential clinical implications of innate and adaptive immune mediators and their regulation in NEC. |Age Factors [MESH] |Animals [MESH] |Biomarkers [MESH] |Clinical Trials as Topic [MESH] |Disease Models, Animal [MESH] |Disease Progression [MESH] |Disease Susceptibility/*immunology/metabolism [MESH] |Enterocolitis, Necrotizing/diagnosis/epidemiology/*etiology/*metabolism [MESH] |Humans [MESH] |Immune System/cytology/immunology/metabolism [MESH] |Immunity [MESH] |Immunologic Factors/metabolism [MESH] |Patient Outcome Assessment [MESH] |Phenotype [MESH] |Receptors, Immunologic/metabolism [MESH] |Receptors, Pattern Recognition/metabolism [MESH] |Risk Factors [MESH] |Severity of Illness Index [MESH]The immunological landscape in necrotising enterocolitis (epmc).pdf DeepDyve Pubget Overpricing